Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes

NCT02949193 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

222

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: evogliptin
DRUG: Sitagliptin

Sponsor

Dong-A ST Co., Ltd.